Personal tools

Coexpression cluster:C972: Difference between revisions

From FANTOM5_SSTAR

Jump to: navigation, search
No edit summary
No edit summary
Line 3: Line 3:
|gostat_on_coexpression_clusters=GO:0004484!mRNA guanylyltransferase activity!0.0100778500780597!8732$GO:0004651!polynucleotide 5'-phosphatase activity!0.0100778500780597!8732$GO:0019204!nucleotide phosphatase activity!0.0100778500780597!8732$GO:0009452!RNA capping!0.0100778500780597!8732$GO:0006370!mRNA capping!0.0100778500780597!8732$GO:0008192!RNA guanylyltransferase activity!0.0125960147274817!8732$GO:0006397!mRNA processing!0.0266730623567725!8732;55119$GO:0016071!mRNA metabolic process!0.0363574422340447!8732;55119$GO:0010467!gene expression!0.0461902140241185!23469;8732;27107;26098;55119
|gostat_on_coexpression_clusters=GO:0004484!mRNA guanylyltransferase activity!0.0100778500780597!8732$GO:0004651!polynucleotide 5'-phosphatase activity!0.0100778500780597!8732$GO:0019204!nucleotide phosphatase activity!0.0100778500780597!8732$GO:0009452!RNA capping!0.0100778500780597!8732$GO:0006370!mRNA capping!0.0100778500780597!8732$GO:0008192!RNA guanylyltransferase activity!0.0125960147274817!8732$GO:0006397!mRNA processing!0.0266730623567725!8732;55119$GO:0016071!mRNA metabolic process!0.0363574422340447!8732;55119$GO:0010467!gene expression!0.0461902140241185!23469;8732;27107;26098;55119
|id=C972
|id=C972
|ontology_enrichment_celltype=CL:0000037!2.86e-48!172;CL:0000566!2.86e-48!172;CL:0002032!5.21e-44!165;CL:0000837!5.21e-44!165;CL:0000738!2.03e-43!140;CL:0000988!7.05e-43!182;CL:0002031!1.33e-34!124;CL:0002087!1.63e-33!119;CL:0000763!1.67e-23!112;CL:0000049!1.67e-23!112;CL:0000542!4.02e-19!53;CL:0000051!4.02e-19!53;CL:0000838!6.20e-19!52;CL:0000766!7.30e-19!76;CL:0000557!3.02e-16!71;CL:0000839!6.25e-15!70;CL:0000860!1.11e-14!45;CL:0002057!1.29e-14!42;CL:0002009!9.30e-14!65;CL:0002194!5.17e-13!63;CL:0000576!5.17e-13!63;CL:0000040!5.17e-13!63;CL:0000559!5.17e-13!63;CL:0000791!3.56e-11!18;CL:0000789!3.56e-11!18;CL:0002420!3.56e-11!18;CL:0002419!3.56e-11!18;CL:0000790!3.56e-11!18;CL:0000084!1.59e-09!25;CL:0000827!1.59e-09!25;CL:0000945!6.94e-09!24;CL:0000826!6.94e-09!24;CL:0000625!6.72e-08!11;CL:0000236!8.80e-08!14
|ontology_enrichment_disease=
|ontology_enrichment_uberon=UBERON:0002390!1.67e-19!102;UBERON:0003061!1.67e-19!102;UBERON:0002193!1.85e-16!112;UBERON:0007023!9.49e-14!115;UBERON:0002371!1.93e-12!80;UBERON:0001474!2.44e-12!86;UBERON:0002405!6.08e-09!115;UBERON:0004765!1.72e-08!101;UBERON:0001434!1.72e-08!101;UBERON:0000178!9.21e-07!15;UBERON:0000179!9.21e-07!15;UBERON:0000463!9.21e-07!15
}}
}}

Revision as of 15:00, 21 May 2012


Full id: C972_granulocyte_CD4_CD19_Neutrophils_acute_CD8_Eosinophils



Phase1 CAGE Peaks

Hg19::chr10:127408263..127408308,+p1@C10orf137
Hg19::chr11:47788847..47788919,-p1@FNBP4
Hg19::chr18:59854480..59854551,+p1@KIAA1468
Hg19::chr1:109234907..109234996,+p1@PRPF38B
Hg19::chr2:32582184..32582301,+p1@BIRC6
Hg19::chr3:101395963..101395993,-p1@ZBTB11
Hg19::chr6:64345698..64345750,+p2@PHF3
Hg19::chr6:89673299..89673349,-p1@RNGTT


Enriched pathways on this co-expression cluster<b>Summary:</b><br>Canonical pathway gene sets were compiled from Reactome, Wikipathways and KEGG. For the major signaling pathways, the transcriptionally-regulated genes (downstream targets) were obtained from Netpath. Combined, the canonical pathways and downstream targets totaled 489 human gene sets. The corresponding M. musculus gene sets were inferred by homology using the HomoloGene database. Enrichment for each of the canonical 489 pathways and gene sets included in the co-expression cluster was assessed by the hypergeometric probability. The resulting P values were also then adjusted by the Benjamini-Hochberg method for multiple comparisons.<br><b>Analyst: </b>Emmanuel Dimont<br><br>link to source dataset<br>data


No results for this coexpression

Enriched Gene Ontology terms on this co-expression cluster<b>Summary:</b> Results for GOStat analysis on co-expressed clusters. Each cluster with promoters mapping to at least two different genes was analysed with GOStat (PMID: 14962934) with default parameter. <br><b>Analyst:</b> Erik Arner<br><br>link to source dataset<br>data


GO IDGO nameFDR corrected p-value
GO:0004484mRNA guanylyltransferase activity0.0100778500780597
GO:0004651polynucleotide 5'-phosphatase activity0.0100778500780597
GO:0019204nucleotide phosphatase activity0.0100778500780597
GO:0009452RNA capping0.0100778500780597
GO:0006370mRNA capping0.0100778500780597
GO:0008192RNA guanylyltransferase activity0.0125960147274817
GO:0006397mRNA processing0.0266730623567725
GO:0016071mRNA metabolic process0.0363574422340447
GO:0010467gene expression0.0461902140241185



Enriched sample ontology terms on this co-expression cluster<b>Summary:</b>To summarize promoter activities (expression profile of a TSS region) across ~1000 samples, we performed enrichment analysis based on FANTOM5 Sample Ontology (FF ontology). The question here is “in which type of samples the promoter is more active”. To answer this question, we compared expressions (TPMs) in the samples associated with a sample ontology term and the rest of the samples by using the Mann-Whitney rank sum test. To summarize ontologies enriched in this co-expression cluster, we ran the same analysis on an averaged expression profile of all promoters that make up. <b>Analyst:</b> Hideya Kawaji <br><br>links to source dataset<br><br>cell_data<br>uberon_data<br><br>


Cell Type
Ontology termp-valuen
hematopoietic stem cell2.86e-48172
angioblastic mesenchymal cell2.86e-48172
hematopoietic oligopotent progenitor cell5.21e-44165
hematopoietic multipotent progenitor cell5.21e-44165
leukocyte2.03e-43140
hematopoietic cell7.05e-43182
hematopoietic lineage restricted progenitor cell1.33e-34124
nongranular leukocyte1.63e-33119
myeloid cell1.67e-23112
common myeloid progenitor1.67e-23112
lymphocyte4.02e-1953
common lymphoid progenitor4.02e-1953
lymphoid lineage restricted progenitor cell6.20e-1952
myeloid leukocyte7.30e-1976
granulocyte monocyte progenitor cell3.02e-1671
myeloid lineage restricted progenitor cell6.25e-1570
classical monocyte1.11e-1445
CD14-positive, CD16-negative classical monocyte1.29e-1442
macrophage dendritic cell progenitor9.30e-1465
monopoietic cell5.17e-1363
monocyte5.17e-1363
monoblast5.17e-1363
promonocyte5.17e-1363
mature alpha-beta T cell3.56e-1118
alpha-beta T cell3.56e-1118
immature T cell3.56e-1118
mature T cell3.56e-1118
immature alpha-beta T cell3.56e-1118
T cell1.59e-0925
pro-T cell1.59e-0925
lymphocyte of B lineage6.94e-0924
pro-B cell6.94e-0924
CD8-positive, alpha-beta T cell6.72e-0811
B cell8.80e-0814
Uber Anatomy
Ontology termp-valuen
hematopoietic system1.67e-19102
blood island1.67e-19102
hemolymphoid system1.85e-16112
adult organism9.49e-14115
bone marrow1.93e-1280
bone element2.44e-1286
immune system6.08e-09115
skeletal element1.72e-08101
skeletal system1.72e-08101
blood9.21e-0715
haemolymphatic fluid9.21e-0715
organism substance9.21e-0715


Overrepresented TFBS (DNA) motifs on this co-expression cluster<b>Summary:</b>The values shown are the p-values for overrepresentation of the motif in this coexpression cluster. So a small p-value means a strong overrepresentation. <b>Analyst:</b> Michiel de Hoon <br><br>link to source data <br> Novel motifs <br>data <br><br> Jaspar motifs <br>data


Novel motifs



JASPAR motifs

Motifs-log10(p-value)

{{{tfbs_overrepresentation_jaspar}}}



ENCODE TF ChIP-seq peak enrichment analysis<b>Summary:</b> For each TF and each co-expression cluster, the number of promoters with ENCODE TF ChIP signal was compared with the rest of promoters from the robust set using Fisher's exact test. Clusters with significant ChIP enrichment (q <= 0.05) after Benjamini-Hochberg correction were retained. <br><b>Analyst:</b> Erik Arner<br><br>link to source dataset<br><br>data


No analysis results for this cluster

Relative expression of the co-expression cluster<b>Summary:</b>Co-expression clusters are compared against FANTOM5 samples to obtain relative expression. <br><b>Analyst:</b>NA<br><br>link to data source<br> data


This analysis result is provided for C0 - C305 clusters.